For example, SFN has been shown to curb the growth of gefitinib-resistant lung cancer cells by altering the sonic hedgehog (SHH) signaling pathway and reducing the expression of markers associated with lung cancer stem cells. This evidence concerns the gene SHH and lung carcinoma.